Dari CLE ke SLE: Laporan Kasus dari Rumah Sakit Setempat
Laporan Kasus
DOI:
https://doi.org/10.55175/cdk.v52i6.1281Kata Kunci:
Penyakit autoimun, lupus eritematosus kulit, SLEAbstrak
Pendahuluan: Lupus eritematosus (LE) merupakan penyakit yang merupakan gabungan dari berbagai penyakit klinis autoimun yang saling berkaitan. Lupus eritematosus kulit (CLE) adalah spektrum kulit ciri khas dari lupus eritematosus sistemik (SLE). Pengenalan gambaran khas lesi kulit (CLE) ini memungkinkan diagnosis dan penatalaksanaan SLE yang baik. Kasus: Wanita berusia 26 tahun penderita SLE dengan lesi kulit akut (ACLE). Kecurigaan terhadap SLE makin kuat karena titer antibodi antinuklear (ANA) mencapai 1:3.200. Terapi utamanya adalah injeksi methylprednisolone dilanjutkan dengan pengurangan dosis secara bertahap. Pasien dirawat selama 6 hari di rumah sakit dan semua lesi membaik setelah perawatan. Kesimpulan: Pasien pada kasus ini mengalami SLE dengan 6 domain klinis pada kriteria EULAR/ACR 2019 dan skor total 34 (>10). Diagnosis yang lebih dini dan tepat terhadap SLE dapat membuat terapi jadi lebih efektif, terutama jika sudah ada CLE.
Unduhan
Referensi
Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al. Fitzpatrick’s dermatology. 9th Ed. United States: McGraw-Hill Education; 2019. p. 1037.
Tian J, Zhang D, Yao X, Huang Y, Lu Q. Global epidemiology of systemic lupus erythematosus: A comprehensive systematic analysis and modelling study. Ann Rheum Dis. 2023;82(3):351–6. DOI: 10.1136/ard-2022-223035.
Vaillant AAJ, Goyal A, Varacallo M. Systemic lupus erythematosus. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publ. 2023. Available from: http://www.ncbi.nlm.nih.gov/books/NBK535405/.
Aringer M, Petri M. New classification criteria for systemic lupus erythematosus. Curr Opin Rheumatol. 2020;32(6):590–6. DOI: 10.1097/BOR.0000000000000740.
Dima A, Jurcut C, Chasset F, Felten R, Arnaud L. Hydroxychloroquine in systemic lupus erythematosus: Overview of current knowledge. Ther Adv Musculoskelet Dis. 2022;14:1–25. DOI: 10.1177/1759720X211073001.
Borucki R, Werth VP. Expert perspective: An evidence-based approach to refractory cutaneous lupus erythematosus. Arthritis Rheumatol. 2020;72(11):1777–85. DOI: 10.1002/art.41480.
Foulke G, Helm LA, Clebak KT, Helm M. Autoimmune skin conditions: Cutaneous lupus erythematosus. FP Essent. 2023;526:25-36. PMID: 36913660.
Selvaraja M, Too CL, Tan LK, Koay BT, Abdullah M, Shah AM, et al. Human leucocyte antigens profiling in Malay female patients with systemic lupus erythematosus: Are we the same or different? Lupus Sci Med. 2022;9(1):1–14. DOI: 10.1136/lupus-2021-000554.
Tayem MG, Shahin L, Shook J, Kesselman MM. A review of cardiac manifestations in patients with systemic lupus erythematosus and antiphospholipid syndrome with focus on endocarditis. Cureus 2022;14(1):e21698. DOI: 10.7759/cureus.21698.
Jeong DY, Lee SW, Park YH, Choi JH, Kwon YW, Moon G, et al. Genetic variation and systemic lupus erythematosus: A field synopsis and systematic meta-analysis. Autoimmunity Rev. 2018;17:553–66. DOI: 10.1016/j.autrev.2017.12.011.
Tanzilia MF, Tambunan BA, Dewi DNSS. Tinjauan pustaka: Patogenesis dan diagnosis sistemik lupus eritematosus. Syifa’ Med J Kedokt Kes. 2021;11(2):139. DOI: 10.32502/sm.v11i2.2788.
Gounden V, Vashisht R, Jialal I. Hypoalbuminemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK526080/.
Stull C, Sprow G, Werth VP. Cutaneous involvement in systemic lupus erythematosus: A review for the rheumatologist. J Rheumatol. 2023;50(1):27–35. DOI: 10.3899/jrheum.220089.
Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400–12. DOI: 10.1002/art.40930.
Leuchten N, Brinks R, Hoyer A, Schoels M, Aringer M, Johnson S, et al. SAT0415 performance of anti-nuclear antibodies (ana) for classifying systemic lupus erythematosus (SLE): A systematic literature review and meta-regression of diagnostic data. Ann Rheum Dis. 2015;74(Suppl 2):809-10. DOI: 10.1136/annrheumdis-2015-eular.4039.
Kuhn A, Landmann A. The classification and diagnosis of cutaneous lupus erythematosus. J Autoimmun. 2014;48–49:14–9. DOI: 10.1016/j.jaut.2014.01.021.
Herzum A, Gasparini G, Cozzani E, Burlando M, Parodi A. Atypical and rare forms of cutaneous lupus erythematosus: The importance of the diagnosis for the best management of patients. Dermatology 2022;238(2):195–204. DOI: 10.1159/000515766.
Cooper EE, Pisano CE, Shapiro SC. Cutaneous manifestations of “lupus”: Systemic lupus erythematosus and beyond. Int J Rheumatol. 2021;2021:6610509. DOI: 10.1155/2021/6610509.
Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–45. DOI: 10.1136/annrheumdis-2019-215089.
Azrielant S, Ellenbogen E, Peled A, Zemser-Werner V, Samuelov L, Sprecher E, et al. Diffuse facial hyperpigmentation as a presenting sign of lupus erythematosus: Three cases and review of the literature. Case Rep Dermatol. 2021;13(2):263–70. DOI: 10.1159/000515732.
Joseph AK, Abbas LF, Chong BF. Treatments for disease damage in cutaneous lupus erythematosus: A narrative review. Dermatol Ther. 2021;34(5):e15034. DOI: 10.1111/dth.15034.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2025 Kelvin, Louis Rianto, Linda Julianti Wijayadi
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
